QA: Bellerophon Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001600132_2022_Bellerophon_Therapeutics_Inc.pdf

Logs

error Negative Expenses, ignoring company. pre-agg {'expenses': -1800000}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001600132')"}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (calc 2)': 2, '00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 6}}

Edgar->Model Mapping